검색
Brainstorm Cell Therapeutics Inc
BCLI관심 목록에 추가
1.170USD
0.0000.00%
종가 07/02, 13:00（ET）시세는 15분 지연됩니다
9.26M시가총액
손실P/E TTM
자세한 내용은 Brainstorm Cell Therapeutics Inc 회사
BrainStorm Cell Therapeutics Inc. is a developer of autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The neurodegenerative diseases include Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis (PMS), Alzheimer’s disease (AD), and others. The Company is engaged in the clinical development and commercialization of the NurOwn technology platform used to produce autologous mesenchymal stem cells- neurotrophic factors (MSC-NTF) cells. NurOwn leverages cell culture methods to induce autologous bone marrow derived MSCs to secrete high levels of NTFs, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. Autologous MSC-NTF cells is for the treatment of ALS. It has completed a phase III trial in ALS. Its wholly owned subsidiary, BrainStorm Cell Therapeutics Ltd., holds exclusive rights to commercialize NurOwn technology.
Brainstorm Cell Therapeutics Inc 정보
종목 코드 BCLI
회사 이름Brainstorm Cell Therapeutics Inc
상장일May 28, 2003
CEOMr. Chaim Lebovits
직원 수27
유형Ordinary Share
회계 연도 종료May 28
주소1325 Avenue Of Americas
도시NEW YORK
증권 거래소US 'Other OTC' and Grey Market
국가United States of America
우편 번호10019
전화12014880460
웹사이트https://brainstorm-cell.com/
종목 코드 BCLI
상장일May 28, 2003
CEOMr. Chaim Lebovits
Brainstorm Cell Therapeutics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Uri Yablonka
Mr. Uri Yablonka
Director, Executive Vice President, Chief Business Officer, Secretary
Director, Executive Vice President, Chief Business Officer, Secretary
68.46K
--
Dr. Hartoun Hartounian, Ph.D.
Dr. Hartoun Hartounian, Ph.D.
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
52.00K
--
Ms. Alla Patlis, CPA
Ms. Alla Patlis, CPA
Interim Chief Financial Officer, Controller
Interim Chief Financial Officer, Controller
44.35K
+2.07%
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
Director
Director
44.15K
--
Dr. Irit Arbel, Ph.D.
Dr. Irit Arbel, Ph.D.
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
41.05K
--
Mr. Nir Naor, CPA
Mr. Nir Naor, CPA
Independent Director
Independent Director
31.47K
+12.18%
Dr. Ibrahim B. (Bob) Dagher, M.D.
Dr. Ibrahim B. (Bob) Dagher, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Prof. Jacob A. Frenkel, Ph.D.
Prof. Jacob A. Frenkel, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Menghisteab (Menghis) Bairu, M.D.
Dr. Menghisteab (Menghis) Bairu, M.D.
Independent Director
Independent Director
--
--
Dr. Anthony John (Tony) Polverino, Ph.D.
Dr. Anthony John (Tony) Polverino, Ph.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Uri Yablonka
Mr. Uri Yablonka
Director, Executive Vice President, Chief Business Officer, Secretary
Director, Executive Vice President, Chief Business Officer, Secretary
68.46K
--
Dr. Hartoun Hartounian, Ph.D.
Dr. Hartoun Hartounian, Ph.D.
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
52.00K
--
Ms. Alla Patlis, CPA
Ms. Alla Patlis, CPA
Interim Chief Financial Officer, Controller
Interim Chief Financial Officer, Controller
44.35K
+2.07%
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
Director
Director
44.15K
--
Dr. Irit Arbel, Ph.D.
Dr. Irit Arbel, Ph.D.
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
41.05K
--
Mr. Nir Naor, CPA
Mr. Nir Naor, CPA
Independent Director
Independent Director
31.47K
+12.18%
자주 묻는 질문
Brainstorm Cell Therapeutics Inc의 상위 5대 주주는 누구인가요?
Brainstorm Cell Therapeutics Inc의 상위 5대 주주는 다음과 같습니다: Mr. Uri Yablonka
Brainstorm Cell Therapeutics Inc(BCLI)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Brainstorm Cell Therapeutics Inc의 주식을 보유한 기관은 총 77곳이며, 이들이 보유한 주식의 총 가치는 약 400.00로 전체 발행 주식의 0.01%를 차지합니다. 이는 2025Q4 대비 -1195352.00 증가한 수치입니다.